Skip to content

Clinical trials

Terminated Phase 1/2 Hematologic Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hematologic Neoplasms Phase: Phase 1/2 Status: Terminated Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20072
20091
20111
20142
20152
20161
20172
20181
20192
20201
20214

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated20

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center4
Bellicum Pharmaceuticals2
Incyte Corporation2
Baylor College of Medicine1
Bristol-Myers Squibb1
Centre Hospitalier Universitaire de Besancon1
Genenta Science1
Gilead Sciences1
Jennifer Amengual1
Menarini Group1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hematologic Neoplasms20
Myelodysplastic Syndromes7
Leukemia, Myeloid, Acute6
Leukemia5
Lymphoma, Non-Hodgkin5
Lymphoma4
Multiple Myeloma4
Precursor Cell Lymphoblastic Leukemia-Lymphoma3
Anemia2
Anemia, Aplastic2

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.